Unibio CIS ApS: Financial statements 2025
CVR: 37456136
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Unibio CIS ApS (CVR 37456136) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,100,000 and a net result of DKK 2,068,000 compared with DKK -2,197,000 the year before. Equity in the 2025 report amounted to DKK 2,417,000. The solvency ratio was 99.3%.
- Gross Profit
- DKK 2,100,000
- Profit/Loss
- DKK 2,068,000
- Equity
- DKK 2,417,000
- Total Assets
- DKK 2,435,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 2.1 mio. | 2.1 mio. | 2.4 mio. | 0 |
| 2024 | - | - | -2.2 mio. | -2.1 mio. | - |
| 2023 | - | - | -89 t. | 66 t. | - |
| 2022 | - | -29 t. | 22 t. | 155 t. | 0 |
| 2021 | - | -19 t. | -8 t. | 8 t. | 0 |
Official annual report
How creditworthy is Unibio CIS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
On August 13, 2025, the company changed its name from UniBio Russia ApS to Unibio CIS ApS.
Unibio CIS ApS has published its annual report for 2024. The net result was DKK -2,197,000.
About Unibio CIS ApS
Unibio CIS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named UniBio Russia ApS. The management consists of Søren Olrik Eklund and Jess Dragheim. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,100,000 and a net result of DKK 2,068,000 compared with DKK -2,197,000 the year before. Equity in the 2025 report amounted to DKK 2,417,000.